MHUA

MKT CAP:$2M

Meihua International Medical Technologies Co., Ltd.

Market Cap

$2M

Healthcare·Medical - Instruments & Supplies·🇨🇳 China·NASDAQ

Healthcare·Medical·🇨🇳·NASDAQ

Stock Price

$9.90+$7.85 (+382.93%)

Feb 9, 2026

Company Details

Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include...

CEO

Lee Leyi

IPO Date

Feb 16, 2022

Website

www.meihuamed.com

Key Metrics TTM

Revenue

$184M

-11.3% YoY

Net Income

$19M

EPS (Diluted)

$65.28

Free Cash Flow

$12M

Revenue / Share

$576.09

Gross Margin

33.6%

Operating Margin

12.6%

Net Margin

10.1%

FCF Margin

6.6%

P/S

0.0x

P/E

0.1x

Earnings Reports

FY 2025

Jun 30, 2025

$38M-60.8%EPS $9.86

Q2 2025

Jun 30, 2025

$38M-16.2%EPS $9.86

FY 2024

Dec 31, 2024

$97M-0.2%EPS $38.00

Q4 2024

Dec 31, 2024

$52M+5.4%EPS $21.00

Q2 2024

Jun 30, 2024

$45M-5.9%EPS $15.36

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 19	$46M	$19M	$13M
Q4 19	$33M	$13M	$7M
Q2 20	$43M	$19M	$13M
Q4 20	$46M	$18M	$11M
Q2 21	$48M	$18M	$11M
Q4 21	$56M	$21M	$15M
Q2 22	$55M	$21M	$9M
Q4 22	$49M	$17M	$2M
Q2 23	$48M	$17M	$9M
Q4 23	$49M	$16M	$6M
Q2 24	$45M	$15M	$6M
Q4 24	$52M	$18M	$8M
Q2 25	$38M	$13M	$3M

Valuation

Quarter	P/S	P/E
Q2 19	—	—
Q4 19	—	—
Q2 20	—	—
Q4 20	1.1x	5.5x
Q2 21	1.1x	5.6x
Q4 21	1.0x	4.7x
Q2 22	0.6x	3.3x
Q4 22	1.1x	8.6x
Q2 23	0.3x	2.7x
Q4 23	0.1x	1.6x
Q2 24	0.2x	1.8x
Q4 24	0.1x	0.5x
Q2 25	0.1x	0.7x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 19	$3M	$3M
Q4 19	$6M	$6M
Q2 20	$7M	-$9M
Q4 20	-$1M	-$2M
Q2 21	-$2M	-$2M
Q4 21	$2M	$916.8K
Q2 22	-$8M	-$8M
Q4 22	-$1M	-$4M
Q2 23	-$5M	-$10M
Q4 23	$8M	$8M
Q2 24	$1M	$1M
Q4 24	$14M	$13M
Q2 25	-$10M	-$10M

Capital Expenditures

Quarter	CapEx
Q2 19	$154.1K
Q4 19	$112.6K
Q2 20	$16M
Q4 20	$581.9K
Q2 21	$92.9K
Q4 21	$757.4K
Q2 22	$459.2K
Q4 22	$2M
Q2 23	$5M
Q4 23	$180.8K
Q2 24	$10.4K
Q4 24	$123.1K
Q2 25	$10.2K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 21	+4.7%	+10.3%
Q4 21	+66.4%	+52.7%
Q2 22	+26.4%	+51.0%
Q4 22	+6.2%	+32.5%
Q2 23	-0.4%	+6.0%
Q4 23	-12.2%	+6.0%
Q2 24	-17.3%	-14.5%
Q4 24	+6.3%	-7.0%
Q2 25	-21.2%	-11.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 19	$0	0.0%
Q4 19	$0	0.0%
Q2 20	$0	0.0%
Q4 20	$0	0.0%
Q2 21	$0	0.0%
Q4 21	$0	0.0%
Q2 22	$0	0.0%
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q4 23	$0	0.0%
Q2 24	$0	0.0%
Q4 24	$0	0.0%
Q2 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 19	$2M	$2M	$3M
Q4 19	$2M	$2M	$3M
Q2 20	$1M	$2M	$3M
Q4 20	$1M	$2M	$4M
Q2 21	$1M	$2M	$3M
Q4 21	$1M	$2M	$3M
Q2 22	$2M	$2M	$2M
Q4 22	$1M	$4M	$2M
Q2 23	$1M	$2M	$2M
Q4 23	$1M	$6M	$4M
Q2 24	$1M	$3M	$3M
Q4 24	$2M	$2M	$2M
Q2 25	$1M	$3M	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 19	$0	$30M	$30M
Q4 19	$16M	$0	$16M
Q2 20	$10M	$0	$10M
Q4 20	$7M	$0	$7M
Q2 21	$7M	$0	$7M
Q4 21	$8M	$0	$8M
Q2 22	$34M	$0	$34M
Q4 22	$27M	$0	$27M
Q2 23	$18M	$0	$18M
Q4 23	$17M	$0	$17M
Q2 24	$18M	$0	$18M
Q4 24	$16M	$0	$16M
Q2 25	$16M	$0	$16M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 19	200K	—	—
Q4 19	200K	0.0%	—
Q2 20	186K	-7.1%	—
Q4 20	214K	+15.3%	—
Q2 21	200K	-6.7%	0.0%
Q4 21	200K	0.0%	0.0%
Q2 22	229K	+14.4%	+23.1%
Q4 22	239K	+4.7%	+11.7%
Q2 23	239K	0.0%	+19.7%
Q4 23	239K	0.0%	+19.7%
Q2 24	307K	+28.3%	+34.3%
Q4 24	295K	-4.1%	+23.1%
Q2 25	319K	+8.3%	+33.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 19	—	—
Q4 19	—	—
Q2 20	—	—
Q4 20	—	—
Q2 21	—	—
Q4 21	$679.0K	82
Q2 22	$668.7K	82
Q4 22	$598.9K	81
Q2 23	$594.9K	81
Q4 23	$603.8K	81
Q2 24	$559.8K	81
Q4 24	$83.3K	619
Q2 25	$61.4K	619

Revenue / Employee